BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5809 related articles for article (PubMed ID: 3180943)

  • 1. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the Cloudman melanoma cell cycle by prostaglandins E1 and E2 determined by using a 5-bromo-2'-deoxyuridine method of DNA analysis.
    Abdel-Malek ZA; Swope VB; Trinkle LS; Ferroni EN; Boissy RE; Nordlund JJ
    J Cell Physiol; 1988 Aug; 136(2):247-56. PubMed ID: 3137233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements.
    Nüsse M; Jülch M; Geido E; Bruno S; Di Vinci A; Giaretti W; Ruoss K
    Cytometry; 1989 May; 10(3):312-9. PubMed ID: 2496957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
    Jensen PO; Larsen JK; Christensen IJ; van Erp PE
    Cytometry; 1994 Feb; 15(2):154-61. PubMed ID: 8168402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-induced cytostasis: kinetic analysis of bromodeoxyuridine-pulsed cells.
    Stevenson AP; Crissman HA; Stewart CC
    Cytometry; 1985 Nov; 6(6):578-83. PubMed ID: 4064839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell kinetics in mouse epidermis studied by bivariate DNA/bromodeoxyuridine and DNA/keratin flow cytometry.
    Kirkhus B; Clausen OP
    Cytometry; 1990; 11(2):253-60. PubMed ID: 1690627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.
    Nüsse M; Afzal SM; Carr B; Kavanau K
    Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of bromodeoxyuridine incorporation by alteration of the fluorescence emission from nucleic acid binding dyes using only an argon ion laser.
    Frey T
    Cytometry; 1994 Dec; 17(4):310-8. PubMed ID: 7875038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC; McNally NJ; Shrieve DC; Kärcher H
    Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain.
    Ormerod MG; Kubbies M
    Cytometry; 1992; 13(7):678-85. PubMed ID: 1280554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
    Sasaki K; Murakami T; Ogino T; Takahashi M
    Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation.
    Gonchoroff NJ; Greipp PR; Kyle RA; Katzmann JA
    Cytometry; 1985 Nov; 6(6):506-12. PubMed ID: 3905299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle analysis of asynchronous populations.
    Ormerod MG
    Methods Mol Biol; 2004; 263():345-54. PubMed ID: 14976376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric cell-cycle analysis of peripheral blood-activated lymphocyte subsets using staining based on the TdT method for incorporated BrdUrd.
    Dolbeare F; Lopez N; Lopez A; Amigo ML; Ciudad J; Del Cañizo MC; San Miguel JF; Orfao A
    Cytometry; 1996 Dec; 25(4):317-23. PubMed ID: 8946138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four methods of DNA distribution data analysis based on bromodeoxyuridine/DNA bivariate data.
    Lacombe F; Belloc F; Bernard P; Boisseau MR
    Cytometry; 1988 May; 9(3):245-53. PubMed ID: 3378459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
    Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells.
    Juan G; Li X; Darzynkiewicz Z
    Cancer Res; 1997 Mar; 57(5):803-7. PubMed ID: 9041174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 291.